243 related articles for article (PubMed ID: 31200660)
21. Effects of Exercise after Percutaneous Coronary Intervention on Cardiac Function and Cardiovascular Adverse Events in Patients with Coronary Heart Disease: Systematic Review and Meta-Analysis.
Zhang H; Chang R
J Sports Sci Med; 2019 Jun; 18(2):213-222. PubMed ID: 31191090
[TBL] [Abstract][Full Text] [Related]
22. Assessment of cardiac parameters after the administration of nicorandil before primary percutaneous coronary intervention.
Ilyas M; Noor M; Haroon S; Farhat K; Ali S; Wahid M
J Pak Med Assoc; 2024 May; 74(5):917-921. PubMed ID: 38783440
[TBL] [Abstract][Full Text] [Related]
23. Effects of trimetazidine on ventricular remodeling in coronary artery disease patients with left ventricular hypertrophy: the rationale and design of a randomized controlled trial.
Wu L; Luan Y; Li Y; Wang M; He J; Jin C; Zhang W
BMC Cardiovasc Disord; 2020 Jun; 20(1):273. PubMed ID: 32503494
[TBL] [Abstract][Full Text] [Related]
24. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
[TBL] [Abstract][Full Text] [Related]
25. Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention-induced myocardial injury.
Kazmi DH; Kapoor A; Sinha A; Ambesh P; Kashyap S; Khanna R; Kumar S; Garg N; Tewari S; Goel PK
Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S365-S371. PubMed ID: 30595291
[TBL] [Abstract][Full Text] [Related]
26. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
[TBL] [Abstract][Full Text] [Related]
27. Myocardial protective effects of nicorandil during percutaneous coronary intervention in patients with unstable angina.
Kim JH; Jeong MH; Yun KH; Kim KH; Kang DK; Hong SN; Lim SY; Lee SH; Lee YS; Hong YJ; Park HW; Kim W; Ahn YK; Cho JG; Park JC; Kang JC
Circ J; 2005 Mar; 69(3):306-10. PubMed ID: 15731536
[TBL] [Abstract][Full Text] [Related]
28. Protection from procedural myocardial injury by omega-3 polyunsaturated fatty acids (PUFAs): is related with lower levels of creatine kinase-MB (CK-MB) and troponin I?
Foroughinia F; Salamzadeh J; Namazi MH
Cardiovasc Ther; 2013 Oct; 31(5):268-73. PubMed ID: 23134549
[TBL] [Abstract][Full Text] [Related]
29. Nicorandil suppressed myocardial injury after percutaneous coronary intervention.
Isono T; Kamihata H; Sutani Y; Motohiro M; Yamamoto S; Kyoui S; Iharada Y; Kurimoto K; Hara K; Takahashi H; Iwasaka T
Int J Cardiol; 2008 Jan; 123(2):123-8. PubMed ID: 17346816
[TBL] [Abstract][Full Text] [Related]
30. The clinical effect of nicorandil on perioperative myocardial protection in patients undergoing elective PCI: A Systematic Review and Meta-Analysis.
Ye Z; Su Q; Li L
Sci Rep; 2017 Mar; 7():45117. PubMed ID: 28322321
[TBL] [Abstract][Full Text] [Related]
31. Vitamin C for Cardiac Protection during Percutaneous Coronary Intervention: A Systematic Review of Randomized Controlled Trials.
Khan SA; Bhattacharjee S; Ghani MOA; Walden R; Chen QM
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32718091
[TBL] [Abstract][Full Text] [Related]
32. Effects of persistent platelet reactivity despite aspirin therapy on cardiac troponin I and creatine kinase-MB levels after elective percutaneous coronary interventions.
Gulmez O; Yildirir A; Kaynar G; Konas D; Aydinalp A; Ertan C; Ozin B; Muderrisoglu H
J Thromb Thrombolysis; 2008 Jun; 25(3):239-46. PubMed ID: 17574519
[TBL] [Abstract][Full Text] [Related]
33. Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation.
Ono H; Osanai T; Ishizaka H; Hanada H; Kamada T; Onodera H; Fujita N; Sasaki S; Matsunaga T; Okumura K
Am Heart J; 2004 Oct; 148(4):E15. PubMed ID: 15459610
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular events associated with nicorandil administration prior to primary percutaneous coronary intervention in patients with acute ST-segment elevated myocardial infarction: a systematic review and meta-analysis.
Li J; Xu X; Zhou X; Dai J; Ma L; Chen C; Li X; Mao W
Expert Opin Drug Saf; 2019 Jun; 18(6):537-547. PubMed ID: 31117845
[No Abstract] [Full Text] [Related]
35. Effect of intravenous application of nicorandil on area of myocardial infarction in patients with STEMI during the perioperative stage of PCI.
Wang ZD; Li H; Liu M; Li P; Chen J; Liang XW; Zhu XZ; Liao W
Clin Hemorheol Microcirc; 2021; 77(4):411-423. PubMed ID: 33386796
[TBL] [Abstract][Full Text] [Related]
36. SUPPORT-1 (Subjects Undergoing PCI and Perioperative Reperfusion Treatment): A Prospective, Randomized Trial of CMX-2043 in Patients Undergoing Elective Percutaneous Coronary Intervention.
Tcheng JE; Gibson M; Krucoff MW; Patel MR; Ajit M; Hiremath J; Ponde C; Ramsaran E; Clark G; Lader AS; Beeuwkes R;
J Cardiovasc Pharmacol; 2020 Aug; 76(2):189-196. PubMed ID: 32769849
[TBL] [Abstract][Full Text] [Related]
37. Nicorandil prevents microvascular dysfunction resulting from PCI in patients with stable angina pectoris: a randomised study.
Hirohata A; Yamamoto K; Hirose E; Kobayashi Y; Takafuji H; Sano F; Matsumoto K; Ohara M; Yoshioka R; Takinami H; Ohe T
EuroIntervention; 2014 Jan; 9(9):1050-6. PubMed ID: 24457276
[TBL] [Abstract][Full Text] [Related]
38. Effect of nicorandil administration on cardiac burden and cardio-ankle vascular index after coronary intervention.
Sato S; Takahashi M; Mikamo H; Kawazoe M; Iizuka T; Shimizu K; Noro M; Shirai K
Heart Vessels; 2020 Dec; 35(12):1664-1671. PubMed ID: 32572567
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of nicorandil on perioperative myocardial injury in patients undergoing elective percutaneous coronary intervention: results of the PENMIPCI trial.
Ye Z; Lu H; Su Q; Long M; Li L
Drug Des Devel Ther; 2018; 12():2591-2599. PubMed ID: 30174413
[TBL] [Abstract][Full Text] [Related]
40. The effect of trimetazidine treatment in patients with type 2 diabetes undergoing percutaneous coronary intervention for AMI.
Li R; Tang X; Jing Q; Wang Q; Yang M; Han X; Zhao J; Yu X
Am J Emerg Med; 2017 Nov; 35(11):1657-1661. PubMed ID: 28587952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
